Newly approved myeloma treatment found highly effective in first real-world patient population
In a first test of more typical patients with multiple myeloma, a newly FDA-approved drug proved nearly as effective as in clinical trial
Emerging STING therapy combined with current standard could treat aggressive AML
CANCER DIGEST – May 12, 2024 – A new combination therapy may offer new hope to patients with an aggressive form of common leukemia,...
Dual targeted cell therapy offers hope in treatment of brain cancer
CANCER DIGEST – March 16, 2024 – Using CAR T cell therapy that targets two proteins associated with the most common and most aggressive...
Advanced non-small cell lung cancer patients gain survival boost with new combination therapy
CANCER DIGEST – Feb. 24, 2024 – Patients with non-small cell lung cancer who have not responded to standard therapy achieved better...
Immunotherapy breakthrough in bladder cancer
CANCER DIGEST – Nov. 25, 2023 – A large Dutch trial confirms the results of a US study showing the addition of immunotherapy to...
Immunotherapy before and after surgery improved lung cancer outcomes
CANCER DIGEST -- Oct. 27, 2023 -- Lung cancer patients who underwent immunotherapy before and after surgery had a 32 percent lower risk...
